Completed PHASE2 INTERVENTIONAL 1-arm NCT00914615

Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3)

Phase II Trial of Stereotactic Body Radiation Therapy for Unresectable Liver Metastases From Colorectal Carcinoma

Sponsor: University Health Network, Toronto

Interventions Stereotactic Body Radiation

Updated 9 times since 2017 Last updated: Oct 4, 2021 Started: Aug 31, 2007 Primary completion: Aug 16, 2019 Completion: Aug 7, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00914615, this PHASE2 trial focuses on Liver Metastasis and remains completed. Sponsored by University Health Network, Toronto, it has been updated 9 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Nov 2021 — Jul 2024 [monthly]

Completed PHASE2
May 2021 — Nov 2021 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Jan 2021 — May 2021 [monthly]

Active Not Recruiting PHASE2

▶ Show 4 earlier versions

Dec 2019 — Jan 2021 [monthly]

Active Not Recruiting PHASE2
Oct 2018 — Dec 2019 [monthly]

Active Not Recruiting PHASE2
Jun 2018 — Oct 2018 [monthly]

Active Not Recruiting PHASE2
Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE2

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Health Network, Toronto

Data source: University Health Network, Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada